
Loading, please wait...

Loading, please wait...

This study of 10 patients with left-sided breast cancer treated using DIBH radiotherapy found that heart and LAD motion significantly impacted radiation dose distribution. Organ shifts along X, Y, and Z axes correlated with key dose metrics. Standard CT-based planning may underestimate true exposure. Adjusting planning margins based on motion data can improve accuracy and minimize radiation to cardiac structures.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study of 10 patients with left-sided breast cancer treated using DIBH radiotherapy found that heart and LAD motion significantly impacted radiation dose distribution. Organ shifts along X, Y, and Z axes correlated with key dose metrics. Standard CT-based planning may underestimate true exposure. Adjusting planning margins based on motion data can improve accuracy and minimize radiation to cardiac structures.
2 months ago

Co-administering antiseizure medications and DOACs frequently causes pharmacokinetic interactions, subtherapeutic drug levels, and thromboembolic failures. This review highlights enzyme induction risks, unpredictable outcomes with levetiracetam, and the vital role of therapeutic drug monitoring.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today